BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magro F, Portela F, Lago P, Ramos de Deus J, Vieira A, Peixe P, Cremers I, Cotter J, Cravo M, Tavares L, Reis J, Gonçalves R, Lopes H, Caldeira P, Ministro P, Carvalho L, Azevedo L, da Costa-Pereira A; GEDII. Crohn's disease in a southern European country: Montreal classification and clinical activity. Inflamm Bowel Dis 2009;15:1343-50. [PMID: 19235885 DOI: 10.1002/ibd.20901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wu YC, Xiao ZB, Lin XH, Zheng XY, Cao DR, Zhang ZS. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease. World J Gastroenterol 2020; 26(39): 6057-6073 [PMID: 33132655 DOI: 10.3748/wjg.v26.i39.6057] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Azevedo LF, Magro F, Portela F, Lago P, Deus J, Cotter J, Cremers I, Vieira A, Peixe P, Caldeira P, Lopes H, Gonçalves R, Reis J, Cravo M, Barros L, Ministro P, Lurdes M, Duarte A, Campos M, Carvalho L, Costa-pereira A. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach: PREVALENCE OF IBD IN PORTUGAL-A PHARMACO-EPIDEMIOLOGICAL APPROACH. Pharmacoepidem Drug Safe 2010;19:499-510. [DOI: 10.1002/pds.1930] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
3 Magro F, Barreiro-de Acosta M, Lago P, Carpio D, Cotter J, Echarri A, Gonçalves R, Pereira S, Carvalho L, Lorenzo A, Barros L, Castro J, Dias JA, Rodrigues S, Portela F, Dias C, da Costa-pereira A. Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events. Journal of Crohn's and Colitis 2010;4:301-11. [DOI: 10.1016/j.crohns.2009.12.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Torres EA, Cruz A, Monagas M, Bernal M, Correa Y, Cordero R, Carlo VL. Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD Registry. Int J Inflam 2012;2012:574079. [PMID: 22195289 DOI: 10.1155/2012/574079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
5 de Barros KSC, Flores C, Harlacher L, Francesconi CFM. Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery. Dig Dis Sci 2017;62:2481-8. [PMID: 28748409 DOI: 10.1007/s10620-017-4685-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
6 Yoon J, Kim DS, Kim YJ, Lee JW, Hong SW, Hwang HW, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease . World J Gastroenterol 2021; 27(19): 2353-2365 [PMID: 34040327 DOI: 10.3748/wjg.v27.i19.2353] [Reference Citation Analysis]
7 Chen H, Lee A, Bowcock A, Zhu W, Li E, Ciorba M, Hunt S. Influence of Crohn's disease risk alleles and smoking on disease location. Dis Colon Rectum 2011;54:1020-5. [PMID: 21730793 DOI: 10.1007/DCR.0b013e31821b94b3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
8 Shinzaki S, Kuroki E, Iijima H, Tatsunaka N, Ishii M, Fujii H, Kamada Y, Kobayashi T, Shibukawa N, Inoue T, Tsujii M, Takeishi S, Mizushima T, Ogata A, Naka T, Plevy SE, Takehara T, Miyoshi E. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease. Inflamm Bowel Dis 2013;19:321-31. [PMID: 23287897 DOI: 10.1097/MIB.0b013e318280eade] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
9 Torres Udos S, Rodrigues JO, Junqueira MS, Uezato S, Netinho JG. The Montreal classification for Crohn's disease: clinical application to a Brazilian single-center cohort of 90 consecutive patients. Arq Gastroenterol. 2010;47:279-284. [PMID: 21140090 DOI: 10.1590/s0004-28032010000300013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Siddique I, Alazmi W, Al-Ali J, Al-Fadli A, Alateeqi N, Memon A, Hasan F. Clinical epidemiology of Crohn’s disease in Arabs based on the Montreal Classification. Inflamm Bowel Dis. 2012;18:1689-1697. [PMID: 21987450 DOI: 10.1002/ibd.21890] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
11 Torres J, Caprioli F, Katsanos KH, Lobatón T, Micic D, Zerôncio M, Van Assche G, Lee JC, Lindsay JO, Rubin DT, Panaccione R, Colombel JF. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis 2016;10:1385-94. [PMID: 27282402 DOI: 10.1093/ecco-jcc/jjw116] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 10.5] [Reference Citation Analysis]
12 Freire P, Portela F, Donato MM, Ferreira M, Andrade P, Sofia C. CARD15 mutations and perianal fistulating Crohn’s disease: correlation and predictive value of antibiotic response. Dig Dis Sci. 2011;56:853-859. [PMID: 20632099 DOI: 10.1007/s10620-010-1331-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Bechara Cde S, Lacerda Filho A, Ferrari Mde L, Andrade DA, Luz MM, da Silva RG. Montreal classification of patient operated for Crohn's disease and identification of surgical recurrence predictors. Rev Col Bras Cir. 2015;42:97-104. [PMID: 26176675 DOI: 10.1590/0100-69912015002006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
14 Dogan B, Scherl E, Bosworth B, Yantiss R, Altier C, McDonough PL, Jiang ZD, Dupont HL, Garneau P, Harel J, Rishniw M, Simpson KW. Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease. Inflamm Bowel Dis. 2013;19:141-150. [PMID: 22508665 DOI: 10.1002/ibd.22971] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
15 Aljebreen AM, Alharbi OR, Azzam NA, Almalki AS, Alswat KA, Almadi MA. Clinical epidemiology and phenotypic characteristics of Crohn's disease in the central region of Saudi Arabia. Saudi J Gastroenterol 2014;20:162-9. [PMID: 24976279 DOI: 10.4103/1319-3767.132993] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
16 López-Serrano P, Pérez-Calle JL, Pérez-Fernández MT, Fernández-Font JM, Boixeda de Miguel D, Fernández-Rodríguez CM. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol. 2010;45:1464-1471. [PMID: 20704469 DOI: 10.3109/00365521.2010.510575] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]